|
- Ibrutinib: Uses, Dosage, Side Effects, Warnings - Drugs. com
Ibrutinib (Imbruvica) is a type of medication called a kinase inhibitor, which is used to treat various blood cancers and also a serious complication of allogeneic stem cell transplants called chronic graft versus host disease (cGVHD)
- Ibrutinib - NCI - National Cancer Institute
Ibrutinib is approved to treat adults with: Chronic lymphocytic leukemia and small lymphocytic lymphoma Chronic lymphocytic leukemia and small lymphocytic lymphoma that has a chromosome change called 17p deletion Waldenström macroglobulinemia (a type of non-Hodgkin lymphoma)
- Ibrutinib (oral route) - Mayo Clinic
Ibrutinib is used to treat chronic lymphocytic leukemia (CLL) small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL) small lymphocytic leukemia (SLL) in patients with 17p deletion, and Waldenström macroglobulinemia (WM)
- IMBRUVICA® (ibrutinib) | Official Patient Website
Find important information about IMBRUVICA® (ibrutinib) uses, dosing, support, and more on the official patient website See full Prescribing Safety Information
- Ibrutinib: Cancer Treatment Uses, Side Effects, Dosage - MedicineNet
Ibrutinib is a novel targeted therapy for certain cancers of white blood cells in adults and is also used for the treatment of chronic graft versus host disease in adult and pediatric patients Ibrutinib is typically used to treat patients who have received at least one prior therapy
- Imbruvica (ibrutinib) - Uses, Side Effects, and More - WebMD
Imbruvica is a type of medicine called a tyrosine kinase inhibitor It inhibits Bruton’s tyrosine kinase (BTK) on B cells, which are a type of white blood cell When Imbruvica inhibits BTK, it
- Ibrutinib: Side Effects, Uses, Dosage, Interactions, Warnings - RxList
Ibrutinib is a prescription medication used as an inhibitor of Bruton's tyrosine kinase (BTK) used to treat patients with mantle cell lymphoma (MCL) who have received at least one prior therapy Learn about side effects, dosages, drug interactions, and more
- Ibrutinib: MedlinePlus Drug Information
Ibrutinib is used to treat adults with chronic lymphocytic leukemia (CLL; a type of cancer that begins in the white blood cells) and small lymphocytic lymphoma (SLL; a type of cancer that begins mostly in the lymph nodes)
|
|
|